002274.SZ
Jiangsu Huachang Chemical Co., Ltd. [002274.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002274.SZ Stock Summary
Top 10 Correlated ETFs
002274.SZ
Top 10 Correlated Stocks
002274.SZ
In the News
002274.SZ Financial details
Company Rating
Strong Buy
Market Cap
7.67B
Income
582.65M
Revenue
7.94B
Book val./share
5.47
Cash/share
0.89
Dividend
0.3
Dividend %
3.9%
Employees
3.14K
Optionable
No
Shortable
Yes
Earnings
26 Oct 2023
P/E
12.59
Forward P/E
-
PEG
-1.96
P/S
0.92
P/B
1.41
P/C
8.91
P/FCF
13.2
Quick Ratio
0.81
Current Ratio
1.15
Debt / Equity
0.08
LT Debt / Equity
0
-
-
EPS (TTM)
0.62
EPS next Y
-
EPS next Q
-
EPS this Y
-46.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
43.73%
Revenue last 5Y
9.27%
Revenue Q/Q
-9.5%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
14.29%
SMA100
14.29%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.15%
Gross Margin
15%
Oper. Margin
10%
Profit Margin
7%
Payout
55%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.98-8.31
52W High
-0.88%
52W Low
+58.6%
RSI
54
Rel Volume
1.17
Avg Volume
12.99M
Volume
15.16M
Perf Week
0%
Perf Month
1.8%
Perf Quarter
21.07%
Perf Half Y
14.43%
-
-
-
-
Beta
0.781
-
-
Volatility
0.21%, 0.2%
Prev Close
0.89%
Price
7.93
Change
2.19%
002274.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 6.1 | 6.63 | 6.4 | 9.99 | 9.5 | |
| Net income per share | 0.15 | 0.21 | 0.19 | 1.73 | 0.92 | |
| Operating cash flow per share | 0.03 | 0.36 | 0.57 | 1.91 | 1.3 | |
| Free cash flow per share | -0.03 | 0.31 | 0.47 | 1.69 | 1.23 | |
| Cash per share | 0.27 | 0.51 | 0.63 | 0.69 | 0.71 | |
| Book value per share | 2.76 | 2.87 | 2.98 | 4.58 | 5.24 | |
| Tangible book value per share | 2.62 | 2.75 | 2.87 | 4.43 | 5.16 | |
| Share holders equity per share | 2.76 | 2.87 | 2.98 | 4.58 | 5.24 | |
| Interest debt per share | 2.79 | 2.7 | 2.7 | 1.28 | 0.67 | |
| Market cap | 4.46B | 6.12B | 4.53B | 11.94B | 6.94B | |
| Enterprise value | 6.78B | 8.27B | 6.58B | 12.76B | 7.14B | |
| P/E ratio | 31.39 | 30.38 | 24.82 | 7.31 | 7.96 | |
| Price to sales ratio | 0.77 | 0.97 | 0.74 | 1.27 | 0.77 | |
| POCF ratio | 171.57 | 17.77 | 8.41 | 6.65 | 5.61 | |
| PFCF ratio | -143.87 | 20.84 | 10.09 | 7.48 | 5.92 | |
| P/B Ratio | 1.7 | 2.24 | 1.6 | 2.77 | 1.39 | |
| PTB ratio | 1.7 | 2.24 | 1.6 | 2.77 | 1.39 | |
| EV to sales | 1.17 | 1.31 | 1.08 | 1.36 | 0.79 | |
| Enterprise value over EBITDA | 11.31 | 11.25 | 9.46 | 4.92 | 4.47 | |
| EV to operating cash flow | 260.92 | 23.99 | 12.21 | 7.11 | 5.76 | |
| EV to free cash flow | -218.8 | 28.13 | 14.65 | 7.99 | 6.09 | |
| Earnings yield | 0.03 | 0.03 | 0.04 | 0.14 | 0.13 | |
| Free cash flow yield | -0.01 | 0.05 | 0.1 | 0.13 | 0.17 | |
| Debt to equity | 0.98 | 0.9 | 0.87 | 0.27 | 0.12 | |
| Debt to assets | 0.39 | 0.37 | 0.33 | 0.14 | 0.07 | |
| Net debt to EBITDA | 3.87 | 2.92 | 2.94 | 0.32 | 0.12 | |
| Current ratio | 0.39 | 0.44 | 0.58 | 0.84 | 1.08 | |
| Interest coverage | 2.52 | 2.66 | 3.08 | 35.25 | 42.44 | |
| Income quality | 0.18 | 1.71 | 3.09 | 1.11 | 1.45 | |
| Dividend Yield | 0.04 | 0.04 | 0.05 | 0.02 | 0.05 | |
| Payout ratio | 1.31 | 1.09 | 1.18 | 0.11 | 0.39 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -2.19 | -0.15 | -0.17 | -0.11 | -0.05 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
| Capex to depreciation | -0.18 | -0.13 | -0.23 | -0.48 | -0.15 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.04 | 3.69 | 3.58 | 13.36 | 10.39 | |
| ROIC | 0.03 | 0.04 | 0.05 | 0.3 | 0.16 | |
| Return on tangible assets | 0.02 | 0.03 | 0.03 | 0.21 | 0.11 | |
| Graham Net | -3.12 | -2.91 | -2.95 | -1.73 | -1.21 | |
| Working capital | -2.19B | -2.04B | -1.8B | -581.21M | 254.44M | |
| Tangible asset value | 2.49B | 2.62B | 2.73B | 4.18B | 4.91B | |
| Net current asset value | -2.48B | -2.26B | -2.05B | -697.34M | 149.96M | |
| Invested capital | 0.98 | 0.9 | 0.87 | 0.27 | 0.12 | |
| Average receivables | 499.25M | 464.49M | 780.37M | 1.29B | 1.38B | |
| Average payables | 787.77M | 889.25M | 810.46M | 699.49M | 817.94M | |
| Average inventory | 514.75M | 549.09M | 536.35M | 647.28M | 804.31M | |
| Days sales outstanding | 31.34 | 24.88 | 67.64 | 56.29 | 52.61 | |
| Days payables outstanding | 59.86 | 61.38 | 45.6 | 37.97 | 45.44 | |
| Days of inventory on hand | 38.12 | 36.82 | 34.01 | 41.72 | 40.64 | |
| Receivables turnover | 11.65 | 14.67 | 5.4 | 6.48 | 6.94 | |
| Payables turnover | 6.1 | 5.95 | 8 | 9.61 | 8.03 | |
| Inventory turnover | 9.57 | 9.91 | 10.73 | 8.75 | 8.98 | |
| ROE | 0.05 | 0.07 | 0.06 | 0.38 | 0.17 | |
| Capex per share | -0.06 | -0.05 | -0.09 | -0.21 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.11 | 2.04 | 2.14 | 2.18 | 1.97 | |
| Net income per share | 0.06 | 0.12 | 0.22 | 0.14 | 0.14 | |
| Operating cash flow per share | 0.06 | 0.12 | 0.22 | 0.12 | 0.38 | |
| Free cash flow per share | 0.05 | 0.1 | 0.14 | 0.09 | 0.25 | |
| Cash per share | 0.72 | 0.71 | 0.78 | 0.92 | 0.89 | |
| Book value per share | 5.11 | 5.24 | 5.47 | 5.32 | 5.47 | |
| Tangible book value per share | 5.01 | 5.16 | 5.38 | 5.23 | 5.38 | |
| Share holders equity per share | 5.11 | 5.24 | 5.47 | 5.32 | 5.47 | |
| Interest debt per share | 1.05 | 0.64 | 0.7 | 0.67 | 0.45 | |
| Market cap | 7.61B | 6.94B | 7.58B | 7.13B | 6.73B | |
| Enterprise value | 8.16B | 7.14B | 7.76B | 7.29B | 6.66B | |
| P/E ratio | 33.59 | 15.33 | 9.22 | 13.41 | 12.86 | |
| Price to sales ratio | 3.79 | 3.58 | 3.71 | 3.44 | 3.58 | |
| POCF ratio | 134.37 | 61.32 | 36.89 | 65.06 | 18.39 | |
| PFCF ratio | 148.77 | 70.44 | 56.39 | 82.95 | 28.46 | |
| P/B Ratio | 1.56 | 1.39 | 1.46 | 1.41 | 1.29 | |
| PTB ratio | 1.56 | 1.39 | 1.46 | 1.41 | 1.29 | |
| EV to sales | 4.07 | 3.68 | 3.8 | 3.51 | 3.54 | |
| Enterprise value over EBITDA | 73.32 | 51.36 | 29.64 | 46.11 | 37.55 | |
| EV to operating cash flow | 144.18 | 63.07 | 37.76 | 66.48 | 18.19 | |
| EV to free cash flow | 159.63 | 72.44 | 57.73 | 84.76 | 28.14 | |
| Earnings yield | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.04 | |
| Debt to equity | 0.2 | 0.12 | 0.13 | 0.13 | 0.08 | |
| Debt to assets | 0.12 | 0.07 | 0.08 | 0.08 | 0.05 | |
| Net debt to EBITDA | 4.99 | 1.42 | 0.69 | 0.99 | -0.42 | |
| Current ratio | 1.01 | 1.08 | 1.13 | 1.12 | 1.15 | |
| Interest coverage | 7.31 | -260.07 | 50.88 | 87.52 | 29.76 | |
| Income quality | 1 | 1 | 1 | 0.82 | 2.8 | |
| Dividend Yield | 0 | 0 | 0 | 0.04 | 0 | |
| Payout ratio | 0.1 | 0.12 | 0.04 | 2.19 | 0.07 | |
| Sales general and administrative to revenue | 0.08 | -0.06 | 0.03 | -0.02 | 0.09 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.1 | -0.13 | -0.35 | -0.22 | -0.35 | |
| Capex to revenue | 0 | -0.01 | -0.03 | -0.01 | -0.07 | |
| Capex to depreciation | -0.05 | -0.12 | -0.61 | -0.2 | 0.59 | |
| Stock based compensation to revenue | 0 | 0.02 | 0 | 0.01 | -0.01 | |
| Graham number | 2.62 | 3.74 | 5.15 | 4.09 | 4.11 | |
| ROIC | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Return on tangible assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Graham Net | -1.3 | -1.21 | -1.01 | -0.62 | -0.54 | |
| Working capital | 48.1M | 254.44M | 400.55M | 341.85M | 380.38M | |
| Tangible asset value | 4.77B | 4.91B | 5.13B | 4.98B | 5.12B | |
| Net current asset value | -52.69M | 149.96M | 351.86M | 285.17M | 340.97M | |
| Invested capital | 0.2 | 0.12 | 0.13 | 0.13 | 0.08 | |
| Average receivables | 1.6B | 1.34B | 1.32B | 1.36B | 1.29B | |
| Average payables | 591.34M | 750.33M | 872.9M | 731.69M | 637.38M | |
| Average inventory | 722.4M | 769.32M | 798.9M | 691.87M | 600.12M | |
| Days sales outstanding | 61.94 | 60.49 | 59.3 | 59.35 | 58.15 | |
| Days payables outstanding | 29.11 | 50.26 | 43.99 | 32.14 | 36.09 | |
| Days of inventory on hand | 35.96 | 44.95 | 41.28 | 30.68 | 33.5 | |
| Receivables turnover | 1.45 | 1.49 | 1.52 | 1.52 | 1.55 | |
| Payables turnover | 3.09 | 1.79 | 2.05 | 2.8 | 2.49 | |
| Inventory turnover | 2.5 | 2 | 2.18 | 2.93 | 2.69 | |
| ROE | 0.01 | 0.02 | 0.04 | 0.03 | 0.03 | |
| Capex per share | -0.01 | -0.02 | -0.07 | -0.02 | -0.14 |
002274.SZ Frequently Asked Questions
What is Jiangsu Huachang Chemical Co., Ltd. stock symbol ?
Jiangsu Huachang Chemical Co., Ltd. is a CN stock and trading under the symbol 002274.SZ
What is Jiangsu Huachang Chemical Co., Ltd. stock quote today ?
Jiangsu Huachang Chemical Co., Ltd. stock price is $7.93 today.
Is Jiangsu Huachang Chemical Co., Ltd. stock public?
Yes, Jiangsu Huachang Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 12.99M
- Market Capitalization 7.67B
- Employee 3.14K
- CEO Mr. Hu Bo
- Headquarters Zhangjiagang,CN
- IPO Date 2008-09-16
-
Website
https://www.huachangchem.cn 
Jiangsu Huachang Chemical Co., Ltd. manufactures and sells agrochemicals, basic chemicals, fine chemicals, and biochemical products in China. Its products include compound fertilizers, carbamide, industrial sodium carbonate, ammonium chloride, liquid anhydrous ammonia, nitric acids, industrial methyl alcohol, sodium and potassium borohydride, trimethyl borate, hexamethyleneimine, 1,2-propanediol, light calcium silicate building blocks, and amino acids. The company was founded in 1970 and is headquartered in Zhangjiagang, China.
